+ |
LNPEP | down-regulates quantity by destabilization
cleavage
|
Oxytocin |
0.2 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-268552 |
|
|
Homo sapiens |
|
pmid |
sentence |
25767437 |
It has been shown that the steady state of the mature OT form can be controlled by an oxytocinase (P-LAP) that is produced in periphery and centrally by the OT-magnocellular neurons. Noticeably, P-LAP is also expressed in parvocellular OT neurons and in other brain structures| The OT intermediate forms are produced from E16.5 (see above) but the mature amidated OT form is detected only from birth. The released mature form is then degraded by an oxytocinase (PLAP) |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Pathways: | Oxytocin signaling |
+ |
ESR1 | up-regulates quantity by expression
transcriptional regulation
|
OXT |
0.439 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-268546 |
|
|
Homo sapiens |
|
pmid |
sentence |
6153132 |
The human and rat OT promoters could be stimulated by the ligand-activated estrogen receptors ERalpha and ERbeta, the thyroid hormone receptor THRapha, and the retinoic acid receptors RARalpha and RARbeta in a variety of cells (3, 477, 478). However, it is important to note that these results were obtained from cotransfection experiments in cell lines, i.e., under nonphysiological circumstances. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Pathways: | Oxytocin signaling |
+ |
RARA | up-regulates quantity by expression
transcriptional regulation
|
OXT |
0.256 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-268548 |
|
|
Homo sapiens |
|
pmid |
sentence |
6153132 |
The human and rat OT promoters could be stimulated by the ligand-activated estrogen receptors ERalpha and ERbeta, the thyroid hormone receptor THRapha, and the retinoic acid receptors RARalpha and RARbeta in a variety of cells (3, 477, 478). However, it is important to note that these results were obtained from cotransfection experiments in cell lines, i.e., under nonphysiological circumstances. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Pathways: | Oxytocin signaling |
+ |
Oxytocin | up-regulates activity
binding
|
OXTR |
0.2 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-268545 |
|
|
Homo sapiens |
|
pmid |
sentence |
11274341 |
The neurohypophysial peptide oxytocin (OT) and OT-like hormones facilitate reproduction in all vertebrates at several levels. The major site of OT gene expression is the magnocellular neurons of the hypothalamic paraventricular and supraoptic nuclei. In response to a variety of stimuli such as suckling, parturition, or certain kinds of stress, the processed OT peptide is released from the posterior pituitary into the systemic circulation.| The OT receptor is a typical class I G protein-coupled receptor that is primarily coupled via G(q) proteins to phospholipase C-beta. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Pathways: | Oxytocin signaling |
+ |
PCSK5 | up-regulates quantity
cleavage
|
Oxytocin |
0.2 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-270334 |
|
|
Homo sapiens |
Hypophysis |
pmid |
sentence |
11690596 |
Oxytocin-extended form is further cleaved by enzymatic activity to yield the nine-amino-acid active peptide, OT. The proteolysis may involve several pro-hormone convertases, convertase 2 (PC2) (20p11-1-11.2) and convertase 5 (PC5) (9q21.3) (Gabreels et al 1998). Both enzymes are found in OT neurosecretory vesicles and are a part of a family of subtilisen/kexinlike convertases (Seidah et al 1994). It is a product of the OT gene located at human gene locus 20p13 (Rao et al 1992). The processing cascade results in the production of neurophysin I and OT extended form (OT-X), which is OT with a C-terminal, three-amino-acid extension. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Pathways: | Oxytocin signaling |
+ |
Oxytocin | up-regulates
|
GABA-A (a4-b2-d) receptor |
0.2 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-268583 |
|
|
Homo sapiens |
|
pmid |
sentence |
33536967 |
OT inhibits corticotropin-releasing factor (CRF) mRNA expression at the hypothalamus, resulting in antistress and anti-anxiety effects| It has been demonstrated that the inhibitory effect of OT on CRF mRNA expression is not a direct one on CRF neurons. GABAergic neurons are present in the surroundings of the PVN (peri-PVN). These GABA-projecting neurons into the PVN inhibits CRF expression via GABAA receptors |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
CD38 | up-regulates quantity
relocalization
|
OXT |
0.375 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-268544 |
|
|
Mus musculus |
|
pmid |
sentence |
17287729 |
CD38 is critical for social behaviour by regulating oxytocin secretion|Consistently, the plasma level of oxytocin (OT), but not vasopressin, was strongly decreased in CD38-/- mice. Replacement of OT by subcutaneous injection or lentiviral-vector-mediated delivery of human CD38 in the hypothalamus rescued social memory and maternal care in CD38-/- mice. |
|
Publications: |
1 |
Organism: |
Mus Musculus |
Pathways: | Oxytocin signaling |
+ |
PCSK5 | up-regulates quantity
cleavage
|
Neurophysin 1 |
0.2 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-270336 |
|
|
Homo sapiens |
Hypophysis |
pmid |
sentence |
11690596 |
Oxytocin-extended form is further cleaved by enzymatic activity to yield the nine-amino-acid active peptide, OT. The proteolysis may involve several pro-hormone convertases, convertase 2 (PC2) (20p11-1-11.2) and convertase 5 (PC5) (9q21.3) (Gabreels et al 1998). Both enzymes are found in OT neurosecretory vesicles and are a part of a family of subtilisen/kexinlike convertases (Seidah et al 1994). It is a product of the OT gene located at human gene locus 20p13 (Rao et al 1992). The processing cascade results in the production of neurophysin I and OT extended form (OT-X), which is OT with a C-terminal, three-amino-acid extension. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Pathways: | Oxytocin signaling |
+ |
RARB | up-regulates quantity by expression
transcriptional regulation
|
OXT |
0.2 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-268549 |
|
|
Homo sapiens |
|
pmid |
sentence |
6153132 |
The human and rat OT promoters could be stimulated by the ligand-activated estrogen receptors ERalpha and ERbeta, the thyroid hormone receptor THRapha, and the retinoic acid receptors RARalpha and RARbeta in a variety of cells (3, 477, 478). However, it is important to note that these results were obtained from cotransfection experiments in cell lines, i.e., under nonphysiological circumstances. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Pathways: | Oxytocin signaling |
+ |
Oxytocin | up-regulates
|
GABA-A (a1-b1-g2) receptor |
0.2 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-268579 |
|
|
Homo sapiens |
|
pmid |
sentence |
33536967 |
OT inhibits corticotropin-releasing factor (CRF) mRNA expression at the hypothalamus, resulting in antistress and anti-anxiety effects| It has been demonstrated that the inhibitory effect of OT on CRF mRNA expression is not a direct one on CRF neurons. GABAergic neurons are present in the surroundings of the PVN (peri-PVN). These GABA-projecting neurons into the PVN inhibits CRF expression via GABAA receptors |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
Neurophysin 1 | up-regulates quantity
binding
|
Oxytocin |
0.2 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-270351 |
|
|
Homo sapiens |
Pituitary Gland Cell Line |
pmid |
sentence |
9511957 |
Neurophysins I and II (NPI and NPII) serve in the neurosecretory granules of the posterior pituitary as carrier proteins for the neurophyseal hormones oxytocin (OT) and vasopressin (VP), respectively, until the latter are released into blood. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Pathways: | Oxytocin signaling |
+ |
ESR2 | up-regulates quantity by expression
transcriptional regulation
|
OXT |
0.489 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-268547 |
|
|
Homo sapiens |
|
pmid |
sentence |
6153132 |
The human and rat OT promoters could be stimulated by the ligand-activated estrogen receptors ERalpha and ERbeta, the thyroid hormone receptor THRapha, and the retinoic acid receptors RARalpha and RARbeta in a variety of cells (3, 477, 478). However, it is important to note that these results were obtained from cotransfection experiments in cell lines, i.e., under nonphysiological circumstances. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Pathways: | Oxytocin signaling |
+ |
Oxytocin | up-regulates
|
GABA-A |
0.2 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-268578 |
|
|
Homo sapiens |
|
pmid |
sentence |
33536967 |
OT inhibits corticotropin-releasing factor (CRF) mRNA expression at the hypothalamus, resulting in antistress and anti-anxiety effects| It has been demonstrated that the inhibitory effect of OT on CRF mRNA expression is not a direct one on CRF neurons. GABAergic neurons are present in the surroundings of the PVN (peri-PVN). These GABA-projecting neurons into the PVN inhibits CRF expression via GABAA receptors |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Pathways: | Oxytocin signaling |
+ |
Oxytocin | up-regulates
|
GABA-A (a6-b1-g2) receptor |
0.2 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-268586 |
|
|
Homo sapiens |
|
pmid |
sentence |
33536967 |
OT inhibits corticotropin-releasing factor (CRF) mRNA expression at the hypothalamus, resulting in antistress and anti-anxiety effects| It has been demonstrated that the inhibitory effect of OT on CRF mRNA expression is not a direct one on CRF neurons. GABAergic neurons are present in the surroundings of the PVN (peri-PVN). These GABA-projecting neurons into the PVN inhibits CRF expression via GABAA receptors |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
Oxytocin | up-regulates
|
GABA-A (a4-b1-g2) receptor |
0.2 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-268582 |
|
|
Homo sapiens |
|
pmid |
sentence |
33536967 |
OT inhibits corticotropin-releasing factor (CRF) mRNA expression at the hypothalamus, resulting in antistress and anti-anxiety effects| It has been demonstrated that the inhibitory effect of OT on CRF mRNA expression is not a direct one on CRF neurons. GABAergic neurons are present in the surroundings of the PVN (peri-PVN). These GABA-projecting neurons into the PVN inhibits CRF expression via GABAA receptors |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
CPE | up-regulates activity
cleavage
|
Oxytocin |
0.2 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-270338 |
|
|
Homo sapiens |
|
pmid |
sentence |
25767437 |
First, OT preprohormone is produced, that will be cleaved and matured by successive enzymes. The OT gene encodes for the Pre-Pro-OT-Neurophysin I (pre-pro-hormone), which is cleaved by different enzymes to give rise to different OT intermediate forms and to the Neurophysin I, and finally to the mature amidated form that is released (Figure 2). |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
Oxytocin | up-regulates
|
GABA-A (a2-b1-g2) receptor |
0.2 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-268580 |
|
|
Homo sapiens |
|
pmid |
sentence |
33536967 |
OT inhibits corticotropin-releasing factor (CRF) mRNA expression at the hypothalamus, resulting in antistress and anti-anxiety effects| It has been demonstrated that the inhibitory effect of OT on CRF mRNA expression is not a direct one on CRF neurons. GABAergic neurons are present in the surroundings of the PVN (peri-PVN). These GABA-projecting neurons into the PVN inhibits CRF expression via GABAA receptors |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
THRA | up-regulates quantity by expression
transcriptional regulation
|
OXT |
0.2 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-268550 |
|
|
Homo sapiens |
|
pmid |
sentence |
6153132 |
The human and rat OT promoters could be stimulated by the ligand-activated estrogen receptors ERalpha and ERbeta, the thyroid hormone receptor THRapha, and the retinoic acid receptors RARalpha and RARbeta in a variety of cells (3, 477, 478). However, it is important to note that these results were obtained from cotransfection experiments in cell lines, i.e., under nonphysiological circumstances. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Pathways: | Oxytocin signaling |
+ |
Oxytocin | up-regulates
|
GABA-A (a3-b1-g2) receptor |
0.2 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-268581 |
|
|
Homo sapiens |
|
pmid |
sentence |
33536967 |
OT inhibits corticotropin-releasing factor (CRF) mRNA expression at the hypothalamus, resulting in antistress and anti-anxiety effects| It has been demonstrated that the inhibitory effect of OT on CRF mRNA expression is not a direct one on CRF neurons. GABAergic neurons are present in the surroundings of the PVN (peri-PVN). These GABA-projecting neurons into the PVN inhibits CRF expression via GABAA receptors |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
PCSK2 | down-regulates quantity
cleavage
|
OXT |
0.269 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-270328 |
|
|
Homo sapiens |
Hypophysis |
pmid |
sentence |
11690596 |
Oxytocin-extended form is further cleaved by enzymatic activity to yield the nine-amino-acid active peptide, OT. The proteolysis may involve several pro-hormone convertases, convertase 2 (PC2) (20p11-1-11.2) and convertase 5 (PC5) (9q21.3) (Gabreels et al 1998). Both enzymes are found in OT neurosecretory vesicles and are a part of a family of subtilisen/kexinlike convertases (Seidah et al 1994). It is a product of the OT gene located at human gene locus 20p13 (Rao et al 1992). The processing cascade results in the production of neurophysin I and OT extended form (OT-X), which is OT with a C-terminal, three-amino-acid extension. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Pathways: | Oxytocin signaling |
+ |
PCSK2 | up-regulates quantity
cleavage
|
Oxytocin |
0.2 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-270335 |
|
|
Homo sapiens |
Hypophysis |
pmid |
sentence |
11690596 |
Oxytocin-extended form is further cleaved by enzymatic activity to yield the nine-amino-acid active peptide, OT. The proteolysis may involve several pro-hormone convertases, convertase 2 (PC2) (20p11-1-11.2) and convertase 5 (PC5) (9q21.3) (Gabreels et al 1998). Both enzymes are found in OT neurosecretory vesicles and are a part of a family of subtilisen/kexinlike convertases (Seidah et al 1994). It is a product of the OT gene located at human gene locus 20p13 (Rao et al 1992). The processing cascade results in the production of neurophysin I and OT extended form (OT-X), which is OT with a C-terminal, three-amino-acid extension. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Pathways: | Oxytocin signaling |
+ |
PAM | up-regulates activity
cleavage
|
Oxytocin |
0.2 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-268551 |
|
|
Homo sapiens |
|
pmid |
sentence |
23084901 |
Nevertheless, overall the results of this study show that peptide sequence recognition is an important aspect of the interactions of the prohormone substrates prooxytocin (3d) and procalcitonin (7e) with PAM, which is mirrored in the potency of analogous peptidomimetic glycolate inhibitors of the enzyme. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Pathways: | Oxytocin signaling |
+ |
Oxytocin | up-regulates
|
GABA-A (a6-b3-d) receptor |
0.2 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-268588 |
|
|
Homo sapiens |
|
pmid |
sentence |
33536967 |
OT inhibits corticotropin-releasing factor (CRF) mRNA expression at the hypothalamus, resulting in antistress and anti-anxiety effects| It has been demonstrated that the inhibitory effect of OT on CRF mRNA expression is not a direct one on CRF neurons. GABAergic neurons are present in the surroundings of the PVN (peri-PVN). These GABA-projecting neurons into the PVN inhibits CRF expression via GABAA receptors |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
Oxytocin | up-regulates
binding
|
OXTR |
0.2 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-16758 |
|
|
Homo sapiens |
|
pmid |
sentence |
1313946 |
The oxytocin receptor, expressed in xenopus oocytes, specifically responds to oxytocin and induces an inward membrane current |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Pathways: | Oxytocin signaling |
+ |
PCSK2 | up-regulates quantity
cleavage
|
Neurophysin 1 |
0.2 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-270337 |
|
|
Homo sapiens |
Hypophysis |
pmid |
sentence |
11690596 |
Oxytocin-extended form is further cleaved by enzymatic activity to yield the nine-amino-acid active peptide, OT. The proteolysis may involve several pro-hormone convertases, convertase 2 (PC2) (20p11-1-11.2) and convertase 5 (PC5) (9q21.3) (Gabreels et al 1998). Both enzymes are found in OT neurosecretory vesicles and are a part of a family of subtilisen/kexinlike convertases (Seidah et al 1994). It is a product of the OT gene located at human gene locus 20p13 (Rao et al 1992). The processing cascade results in the production of neurophysin I and OT extended form (OT-X), which is OT with a C-terminal, three-amino-acid extension. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Pathways: | Oxytocin signaling |
+ |
PCSK5 | down-regulates quantity
cleavage
|
OXT |
0.251 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-270327 |
|
|
Homo sapiens |
Hypophysis |
pmid |
sentence |
11690596 |
Oxytocin-extended form is further cleaved by enzymatic activity to yield the nine-amino-acid active peptide, OT. The proteolysis may involve several pro-hormone convertases, convertase 2 (PC2) (20p11-1-11.2) and convertase 5 (PC5) (9q21.3) (Gabreels et al 1998). Both enzymes are found in OT neurosecretory vesicles and are a part of a family of subtilisen/kexinlike convertases (Seidah et al 1994). It is a product of the OT gene located at human gene locus 20p13 (Rao et al 1992). The processing cascade results in the production of neurophysin I and OT extended form (OT-X), which is OT with a C-terminal, three-amino-acid extension. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Pathways: | Oxytocin signaling |
+ |
TAC1 | up-regulates quantity
|
OXT |
0.576 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-268576 |
|
|
|
|
pmid |
sentence |
35045339 |
Social touch-like tactile stimulation activates a tachykinin 1-oxytocin pathway to promote social interactions|Functionally, activation of PVH-projecting Tac1+ neurons increases firing of oxytocin neurons, promotes social interactions, and increases preference for the social touch context, whereas reducing activity of Tac1+ neurons abolishes ST-induced oxytocin neuronal firing. |
|
Publications: |
1 |
Pathways: | Oxytocin signaling |
+ |
Oxytocin | up-regulates
|
GABA-A (a4-b3-d) receptor |
0.2 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-268584 |
|
|
Homo sapiens |
|
pmid |
sentence |
33536967 |
OT inhibits corticotropin-releasing factor (CRF) mRNA expression at the hypothalamus, resulting in antistress and anti-anxiety effects| It has been demonstrated that the inhibitory effect of OT on CRF mRNA expression is not a direct one on CRF neurons. GABAergic neurons are present in the surroundings of the PVN (peri-PVN). These GABA-projecting neurons into the PVN inhibits CRF expression via GABAA receptors |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
Oxytocin | up-regulates
|
GABA-A (a5-b1-g2) receptor |
0.2 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-268585 |
|
|
Homo sapiens |
|
pmid |
sentence |
33536967 |
OT inhibits corticotropin-releasing factor (CRF) mRNA expression at the hypothalamus, resulting in antistress and anti-anxiety effects| It has been demonstrated that the inhibitory effect of OT on CRF mRNA expression is not a direct one on CRF neurons. GABAergic neurons are present in the surroundings of the PVN (peri-PVN). These GABA-projecting neurons into the PVN inhibits CRF expression via GABAA receptors |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
Oxytocin | up-regulates
|
GABA-A (a6-b2-d) receptor |
0.2 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-268587 |
|
|
Homo sapiens |
|
pmid |
sentence |
33536967 |
OT inhibits corticotropin-releasing factor (CRF) mRNA expression at the hypothalamus, resulting in antistress and anti-anxiety effects| It has been demonstrated that the inhibitory effect of OT on CRF mRNA expression is not a direct one on CRF neurons. GABAergic neurons are present in the surroundings of the PVN (peri-PVN). These GABA-projecting neurons into the PVN inhibits CRF expression via GABAA receptors |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
CAPRIN2 | up-regulates quantity by stabilization
post transcriptional regulation
|
OXT |
0.2 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-268556 |
|
|
Homo sapiens |
HEK-293 Cell |
pmid |
sentence |
35051932 |
Transcriptional and post-transcriptional regulation of oxytocin and vasopressin gene expression by CREB3L1 and CAPRIN2|Altogether, the data indicate that CAPRIN2 binds Oxt mRNA |Therefore, we propose that CAPRIN2 facilitates post-transcriptional modifications that increase Oxt transcript stability. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Pathways: | Oxytocin signaling |
+ |
CREB3L1 | up-regulates quantity by expression
transcriptional regulation
|
OXT |
0.2 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-268555 |
|
|
Homo sapiens |
HEK-293 Cell |
pmid |
sentence |
35051932 |
Transcriptional and post-transcriptional regulation of oxytocin and vasopressin gene expression by CREB3L1 and CAPRIN2|By luciferase assays, we demonstrate that CREB3L1 may be a transcription factor regulating Oxt gene expression. By RNA immunoprecipitation assays and northern blot analysis of Oxt mRNA poly(A) tails, we have found that CAPRIN2 binds Oxt mRNA and regulates its poly(A) tail length.|To investigate transcriptional regulation of the OXT gene by CREB3L1, we performed luciferase assays using a proximal Oxt promoter region transfected in HEK293T cells. The expression of full-length CREB3L1 (CREB3L1FL) and a constitutively active CREB3L1 (CREB3L1CA) significantly increased luciferase activity by 5.4- and 3.2-fold, respectively, compared with controls |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Pathways: | Oxytocin signaling |